SCRI at Mary Crowley — Dallas, Texas

SCRI at Mary Crowley is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

SCRI at Mary Crowley has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: TP53 Y220C Mutation, Advanced Solid Tumors, Solid Tumor, Adult.

Sponsors: PMV Pharmaceuticals, Inc, TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics), Context Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI at Mary Crowley?

SCRI at Mary Crowley has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI at Mary Crowley conducted?

SCRI at Mary Crowley has 3 clinical trials on record, with 3 currently active. Their work covers TP53 Y220C Mutation, Advanced Solid Tumors, Solid Tumor, Adult.

Is SCRI at Mary Crowley accredited by Crixeo Health?

SCRI at Mary Crowley has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI at Mary Crowley?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.